Discovery of LHRH and development of LHRH analogs for prostate cancer treatment.

about

Gonadotropin-Releasing Hormone (GnRH) Receptor Structure and GnRH Binding.Evolutionary Viewpoint on GnRH (gonadotropin-releasing hormone) in Chordata - Amino Acid and Nucleic Acid Sequences.Checks and balances occur not only in government, but also in biology

P2860

Q47130308-86AFE8C7-D76F-456F-90F1-C0C74C084B29 Q55716781-85248677-4F02-4770-91BE-E7C52B781754 Q58764435-6E39675B-FAB6-4D8F-9FFF-D21B2D6F2545

P2860

Discovery of LHRH and development of LHRH analogs for prostate cancer treatment.

Item

http://www.wikidata.org/entity/Q39267156

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Discovery of LHRH and development of LHRH analogs for prostate cancer treatment.

@en

Discovery of LHRH and development of LHRH analogs for prostate cancer treatment.

@nl

type

Item

label

Discovery of LHRH and development of LHRH analogs for prostate cancer treatment.

@en

Discovery of LHRH and development of LHRH analogs for prostate cancer treatment.

@nl

prefLabel

Discovery of LHRH and development of LHRH analogs for prostate cancer treatment.

@en

Discovery of LHRH and development of LHRH analogs for prostate cancer treatment.

@nl

P1476

Discovery of LHRH and development of LHRH analogs for prostate cancer treatment.

@en

P2093

Ferenc G Rick

http://www.w3.org/2001/XMLSchema#string

Norman L Block

http://www.w3.org/2001/XMLSchema#string

P2860

Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent

Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Gonadotropin-releasing hormone receptors

GnRHs and GnRH receptors

A chemically labeled cytotoxic agent: two-photon fluorophore for optical tracking of cellular pathway in chemotherapy

Risk of hormone escape in a human prostate cancer model depends on therapy modalities and can be reduced by tyrosine kinase inhibitors

Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) system.

Gonadotropin-releasing hormone analog structural determinants of selectivity for inhibition of cell growth: support for the concept of ligand-induced selective signaling.

P304

1036-1054

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PROS.23360

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andrew Schally

P577

2017-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28449236

http://www.w3.org/2001/XMLSchema#string

Discovery of LHRH and development of LHRH analogs for prostate cancer treatment.

about

P2860

P2860

Discovery of LHRH and development of LHRH analogs for prostate cancer treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698